I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
5.07
+0.70 (16.02%)
At close: Oct 8, 2025, 4:00 PM EDT
5.17
+0.10 (1.97%)
After-hours: Oct 8, 2025, 5:03 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $584.40 million as of October 8, 2025. Its market cap has increased by 564.47% in one year.
Market Cap
584.40M
Enterprise Value
438.40M
1-Year Change
564.47%
Ranking
Category
Stock Price
$5.07
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has increased from $138.05M to $584.40M, an increase of 323.33%. That is a compound annual growth rate of 28.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 503.71M | 627.70% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |